Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;12(Suppl 1):S1-S4.
doi: 10.5005/jp-journals-10018-1363.

NAFLD vs MAFLD: South Asian NAFLD Patients don't Favor Name Change

Shivaram P Singh  1 , Prajna Anirvan  1 , Amna S Butt  2 , Ananta Shrestha  3 , Anuradha S Dassanayake  4 , Bashir A Shaikh  5 , Mamun A Mahtab  6
Affiliations

NAFLD vs MAFLD: South Asian NAFLD Patients don't Favor Name Change

Shivaram P Singh et al. Euroasian J Hepatogastroenterol. 2022 Jul.

Abstract

Aim: There have been vociferous attempts to change the name of Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Associated Fatty Liver Disease (MAFLD). Of the many arguments put forth in support of this, an important one is the presumed demand by patient groups insisting on the change. However, this claim does not have credible evidence to support it. Therefore, we decided to conduct a survey among South Asian NAFLD patients to understand their perspectives with regard to the change in nomenclature.

Materials and methods: The study was conducted at multiple centers across South Asia from January 2021 to June 2021. Patients were surveyed using an 8-question survey questionnaire and responses were categorized by multiple-choice format.

Results: Of 218 patients surveyed, 80.3% of the patients were not aware of the entity "NAFLD" before they were first diagnosed. Although 74.3% of patients admitted to being questioned about alcohol intake at the time of the first diagnosis, 75.9% of female patients were not questioned regarding this. After being labelled NAFLD, 92.1% of patients were never questioned again about alcohol intake. While 86.3% of patients found the term "NAFLD" consoling, 83% did not feel that "Non" in NAFLD trivialized their problem. In addition, only 6.9% of patients were scared of developing cardiovascular disease.

Conclusion: The term "NAFLD" destigmatizes patients of the taboo associated with alcohol use. It was found to be consoling to most patients and they did not feel it trivialized their problem. A change of name without considering patients' perspectives and peculiarities specific to different populations will have enormous ramifications for both patients and physicians.

Clinical significance: Our survey clearly shows that patients are happy with the term "NAFLD" and it effectively destigmatizes them from the taboo of alcohol. This would lead to higher compliance with management and greater patient participation in future studies and trials.

How to cite this article: Singh SP, Anirvan P, Butt AS, et al. NAFLD vs MAFLD: South Asian NAFLD Patients don't Favor Name Change. Euroasian J Hepato-Gastroenterol 2022;12(Suppl 1):S1-S4.

Keywords: NASH; Nomenclature; South Asia; Steatohepatitis; patients' sentiments.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Fig. 1
Fig. 1
Patients’ awareness of NAFLD before diagnosis
Fig. 2
Fig. 2
Pattern of inquiry regarding alcohol intake
Fig. 3
Fig. 3
Gender disparity in questioning about alcohol intake
Fig. 4
Fig. 4
Patients’ sentiments concerning NAFLD
Fig. 5
Fig. 5
Patients’ concerns regarding the disease
Fig. 6
Fig. 6
Patients’ reasons for concern
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi: 10.1016/j.jhep.2020.03.039. - DOI - PubMed
    1. Eslam M, Sanyal AJ, George J, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.e1. doi: 10.1053/j.gastro.2019.11.312. - DOI - PubMed
    1. Eslam M, Ratziu V, George J. Yet more evidence that MAFLD is more than a name change. J Hepatol. 2021;74(4):977–979. doi: 10.1016/j.jhep.2020.12.025. - DOI - PubMed
    1. Shiha G, Korenjak M, Eskridge W, et al. Redefining fatty liver disease: an international patient perspective. Lancet Gastroenterol Hepatol. 2021;6(1):73–79. doi: 10.1016/S2468-1253(20)30294-6. - DOI - PubMed
    1. Samji NS, Snell PD, Singal AK, et al. Racial disparities in diagnosis and prognosis of nonalcoholic fatty liver disease. Clin Liver Dis. 2020;16(2):66–72. doi: 10.1002/cld.948. - DOI - PMC - PubMed